Ischelium en es it fr

Ischelium Brand names, Ischelium Analogs

Ischelium Brand Names Mixture

  • No information avaliable

Ischelium Chemical_Formula


Ischelium RX_link

No information avaliable

Ischelium fda sheet

Ischelium msds (material safety sheet)

Ischelium Synthesis Reference

No information avaliable

Ischelium Molecular Weight

591.741 g/mol

Ischelium Melting Point

No information avaliable

Ischelium H2O Solubility

No information avaliable

Ischelium State


Ischelium LogP


Ischelium Dosage Forms

Capsule; Liquid; Powder; Powder for solution; Solution; Syrup; Tablet

Ischelium Indication

For use as an adjunct therapy for patients with dementia

Ischelium Pharmacology

Ergoloid Mesylate may increase cerebral metabolism and blood flow. The role of this medication in the therapy of dementia is controversial. A recent controlled study in patients with Alzheimer's disease found that there was no advantage to the use of ergoloid mesylates compared to placebo, suggesting that ergoloid mesylates may lower scores on some cognitive and behavioral rating scales. Further study is needed to determine the risk-benefit profile of ergoloid mesylates in the treatment of dementia.

Ischelium Absorption

Rapidly but incompletely (approximately 25%) absorbed from the gastrointestinal tract. Approximately 50% of the absorbed dose is eliminated by first-pass metabolism.

Ischelium side effects and Toxicity

Symptoms of overdose include dyspnea, hypotension or hypertension, rapid weak pulse, delirium, nausea, vomiting, and bradycardia.

Ischelium Patient Information

No information avaliable

Ischelium Organisms Affected

Humans and other mammals